3D cell cultures of human head and neck squamous cell carcinoma cells are radiosensitized by the focal adhesion kinase inhibitor TAE226

Radiotherapy and Oncology

Volumn 92, Issue 3, 2009, Pages 371-378

  Hehlgans, Stephanie ^a   Lange, Inga ^a   Eke, Iris ^a   Cordes, Nils ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Akt; FAK; Ionizing radiation; Squamous cell carcinoma; Three dimensional cell culture

Indexed keywords

FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; PROTEIN TYROSINE KINASE INHIBITOR; SOMATOMEDIN C RECEPTOR; TAE 226; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CLONOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG POTENCY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IONIZING RADIATION; LUNG CANCER; PANCREAS TUMOR; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; RADIOSENSITIZATION; SQUAMOUS CELL CARCINOMA;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; MORPHOLINES; PANCREATIC NEOPLASMS; PROBABILITY; RADIATION TOLERANCE; RADIATION, IONIZING; TUMOR CELLS, CULTURED;

EID: 69949162504     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.08.001     Document Type: Article

References (48)

1. Baumann M., Krause M., and Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer 8 (2008) 545-554
2. Dean M. Cancer stem cells: redefining the paradigm of cancer treatment strategies. Mol Interv 6 (2006) 140-148
3. Dean M., Fojo T., and Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 5 (2005) 275-284
4. Milas L., Raju U., Liao Z., and Ajani J. Targeting molecular determinants of tumor chemo-radioresistance. Semin Oncol 32 (2005) S78-S81
5. Baumann M., Krause M., Dikomey E., et al. EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms. Radiother Oncol 83 (2007) 238-248
6. Cordes N., and Meineke V. Cell adhesion-mediated radioresistance (CAM-RR) extracellular matrix-dependent improvement of cell survival in human tumor and normal cells in vitro. Strahlenther Onkol 179 (2003) 337-344
7. Hehlgans S., Haase M., and Cordes N. Signalling via integrins: implications for cell survival and anticancer strategies. Biochim Biophys Acta 1775 (2007) 163-180
8. Jacobs C.I. A review of the role of insulin-like growth factor 2 in malignancy and its potential as a modifier of radiation sensitivity. Clin Oncol [R Coll Radiol] 20 (2008) 345-352
9. Eke I., Sandfort V., Mischkus A., Baumann M., and Cordes N. Antiproliferative effects of EGFR tyrosine kinase inhibition and radiation-induced genotoxic injury are attenuated by adhesion to fibronectin. Radiother Oncol 80 (2006) 178-184
10. Eke I., Sandfort V., Storch K., Baumann M., Roper B., and Cordes N. Pharmacological inhibition of EGFR tyrosine kinase affects ILK-mediated cellular radiosensitization in vitro. Int J Radiat Biol 83 (2007) 793-802
11. Parsons J.T., Slack-Davis J., Tilghman R., and Roberts W.G. Focal adhesion kinase: targeting adhesion signaling pathways for therapeutic intervention. Clin Cancer Res 14 (2008) 627-632
12. Sastry S.K., and Burridge K. Focal adhesions: a nexus for intracellular signaling and cytoskeletal dynamics. Exp Cell Res 261 (2000) 25-36
13. Cance W.G., Harris J.E., Iacocca M.V., et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res 6 (2000) 2417-2423
14. Glukhova M., Koteliansky V., Sastre X., and Thiery J.P. Adhesion systems in normal breast and in invasive breast carcinoma. Am J Pathol 146 (1995) 706-716
15. Han N.M., Fleming R.Y., Curley S.A., and Gallick G.E. Overexpression of focal adhesion kinase (p125FAK) in human colorectal carcinoma liver metastases: independence from c-src or c-yes activation. Ann Surg Oncol 4 (1997) 264-268
16. Hsu N.Y., Chen C.Y., Hsu C.P., et al. Prognostic significance of expression of nm23-H1 and focal adhesion kinase in non-small cell lung cancer. Oncol Rep 18 (2007) 81-85
17. Kornberg L.J. Focal adhesion kinase expression in oral cancers. Head Neck 20 (1998) 634-639
18. Owens L.V., Xu L., Craven R.J., et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res 55 (1995) 2752-2755
19. Sakurama K., Noma K., Takaoka M., et al. Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor. Mol Cancer Ther 8 (2009) 127-134
20. Sood A.K., Coffin J.E., Schneider G.B., et al. Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. Am J Pathol 165 (2004) 1087-1095
21. Beinke C., Van Beuningen D., and Cordes N. Ionizing radiation modules of the expression and tyrosine phosphorylation of the focal adhesion-associated proteins focal adhesion kinase (FAK) and its substrates p130cas and paxillin in A549 human lung carcinoma cells in vitro. Int J Radiat Biol 79 (2003) 721-731
22. Cordes N., Frick S., Brunner T.B., et al. Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1. Oncogene 26 (2007) 6851-6862
23. Kasahara T., Koguchi E., Funakoshi M., Aizu-Yokota E., and Sonoda Y. Antiapoptotic action of focal adhesion kinase (FAK) against ionizing radiation. Antioxid Redox Signal 4 (2002) 491-499
24. McLean G.W., Carragher N.O., Avizienyte E., Evans J., Brunton V.G., and Frame M.C. The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer 5 (2005) 505-515
25. Sonoda Y., Matsumoto Y., Funakoshi M., Yamamoto D., Hanks S.K., and Kasahara T. Anti-apoptotic role of focal adhesion kinase (FAK). Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60. J Biol Chem 275 (2000) 16309-16315
26. Yee K.L., Weaver V.M., and Hammer D.A. Integrin-mediated signalling through the MAP-kinase pathway. IET Syst Biol 2 (2008) 8-15
27. Lim S.T., Mikolon D., Stupack D.G., and Schlaepfer D.D. FERM control of FAK function: implications for cancer therapy. Cell Cycle 7 (2008) 2306-2314
28. Zhao J., and Guan J.L. Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev (2009)
29. Beierle E.A., Trujillo A., Nagaram A., et al. N-MYC regulates focal adhesion kinase expression in human neuroblastoma. J Biol Chem 282 (2007) 12503-12516
30. Golubovskaya V., Beviglia L., Xu L.H., Earp III H.S., Craven R., and Cance W. Dual inhibition of focal adhesion kinase and epidermal growth factor receptor pathways cooperatively induces death receptor-mediated apoptosis in human breast cancer cells. J Biol Chem 277 (2002) 38978-38987
31. Halder J., Landen Jr. C.N., Lutgendorf S.K., et al. Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells. Clin Cancer Res 11 (2005) 8829-8836
32. Xu L.H., Yang X., Bradham C.A., et al. The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells. Involvement of death receptor-related signaling pathways. J Biol Chem 275 (2000) 30597-30604
33. Roberts W.G., Ung E., Whalen P., et al. Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562, 271. Cancer Res 68 (2008) 1935-1944
34. Slack-Davis J.K., Martin K.H., Tilghman R.W., et al. Cellular characterization of a novel focal adhesion kinase inhibitor. J Biol Chem 282 (2007) 14845-14852
35. Beierle E.A., Trujillo A., Nagaram A., Golubovskaya V.M., Cance W.G., and Kurenova E.V. TAE226 inhibits human neuroblastoma cell survival. Cancer Invest 26 (2008) 145-151
36. Golubovskaya V.M., Virnig C., and Cance W.G. TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR. Mol Carcinog 47 (2008) 222-234
37. Shi Q., Hjelmeland A.B., Keir S.T., et al. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth. Mol Carcinog 46 (2007) 488-496
38. Wang Z.G., Fukazawa T., Nishikawa T., et al. TAE226, a dual inhibitor for FAK and IGF-IR, has inhibitory effects on mTOR signaling in esophageal cancer cells. Oncol Rep 20 (2008) 1473-1477
39. Watanabe N., Takaoka M., Sakurama K., et al. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo. Clin Cancer Res 14 (2008) 4631-4639
40. Hehlgans S., Eke I., Deuse Y., and Cordes N. Integrin-linked kinase: dispensable for radiation survival of three-dimensionally cultured fibroblasts. Radiother Oncol 86 (2008) 329-335
41. Yaromina A., Krause M., Thames H., et al. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation. Radiother Oncol 83 (2007) 304-310
42. Sawada M., and Sato M. The effect of dimethyl sulfoxide on the neuronal excitability and cholinergic transmission in aplysia ganglion cells. Ann NY Acad Sci 243 (1975) 337-357
43. Fukumoto H., Matsui Y., and Obinata M. Mechanism of erythropoietin action on the erythroid progenitor cells induced from murine erythroleukemia cells (TSA8). Development 105 (1989) 109-114
44. Absolom D.R., Neumann A.W., Zingg W., and van Oss C.J. Thermodynamic studies of cellular adhesion. Trans Am Soc Artif Intern Organs 25 (1979) 152-158
45. McIntyre L.J., and Kim Y.S. Effects of sodium butyrate and dimethylsulfoxide on human pancreatic tumor cell lines. Eur J Cancer Clin Oncol 20 (1984) 265-271
46. Janes S.M., and Watt F.M. New roles for integrins in squamous-cell carcinoma. Nat Rev Cancer 6 (2006) 175-183
47. al-Obeidi F.A., Wu J.J., and Lam K.S. Protein tyrosine kinases: structure, substrate specificity, and drug discovery. Biopolymers 47 (1998) 197-223
48. Ross G.M. Induction of cell death by radiotherapy. Endocr Relat Cancer 6 (1999) 41-44